Evidence map›Paper›PMID 42576757›Full record

ArticleHua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology2026

[Screening of potential bioactive constituents in wall-broken

Juan Liu, Jiaqi Wang, Yuan Li, Yuyi Cong, Xiaobing Guan

Abstract readEnglish Abstract
In one paragraph

Article in Hua xi kou qiang yi xue za zhi = Huaxi kouqiang yixue zazhi = West China journal of stomatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Juan LiuBeijing Stomatological Hospital, Capital Medical University, School of Stomatology, Capital Medical University, Beijing 100071, China.
Jiaqi WangBeijing Stomatological Hospital, Capital Medical University, School of Stomatology, Capital Medical University, Beijing 100071, China.
Yuan LiBeijing Stomatological Hospital, Capital Medical University, School of Stomatology, Capital Medical University, Beijing 100071, China.
Yuyi CongBeijing Stomatological Hospital, Capital Medical University, School of Stomatology, Capital Medical University, Beijing 100071, China.
Xiaobing GuanBeijing Stomatological Hospital, Capital Medical University, School of Stomatology, Capital Medical University, Beijing 100071, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo screen and validate the activity of potential therapeutic substances in wall-broken

methodsThe potential active components of BGLSP were screened through network pharmacology combined with molecular docking and verified via the cell counting kit(CCK)-8 assay, cell scratch assay, and a rat oral ulcer model.​.

resultsNetwork pharmacology revealed that 25 compounds in BGLSP exert prohealing effects through multiple targets and pathways. Molecular docking identified seven compounds with strong binding affinity. On the basis of their relative contents in BGLSP, ganoderic acid A (GAA) and ganoderic acid G (GAG) were identified as the key potential active constituents promoting ulcer healing. At low concentrations, GAA and GAG showed no cytotoxicity. GAA promoted the migration of human primary gingival fibroblasts in a concentration-dependent manner, whereas GAG showed a promotive effect only at 2.5 µmol/L. GAA and GAG enhanced collagen deposition and angiogenesis in rat oral ulcers, accelerating healing. GAA demonstrated a good effect at low concentrations in the early stage of ulcer healing but a superior effect at high concentrations in the later stage of ulcer healing, whereas GAG exhibited a concentration-dependent promotive effect.

Indexed as

Heptanoic AcidsLanosterolOral UlcerReishiSpores, FungalWound HealingAnimalsCell MovementFibroblastsHumansMaleMolecular Docking SimulationNetwork PharmacologyPowdersRatsRats, Sprague-Dawleyganoderic acid AHeptanoic AcidsLanosterolPowdersTriterpenesganoderic acid Aganoderic acid Gnetwork pharmacologyoral ulcerwall-broken Ganoderma lucidum spore powder

Identifiers

PMID42576757
PMCPMC13458852

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.